Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 39Terminated 12Unknown 4Withdrawn 3Recruiting 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Lymphoma, Large B-Cell, Diffuse 21Lymphoma 20Lymphoma, Follicular 16Leukemia, Lymphocytic, Chronic, B-Cell 15Lymphoma, Non-Hodgkin 10Lymphoma, Mantle-Cell 9Lymphoma, B-Cell, Marginal Zone 9Leukemia 9Recurrence 6Burkitt Lymphoma 6Waldenstrom Macroglobulinemia 5Lymphoma, B-Cell 4Lymphoma, Large-Cell, Immunoblastic 3Hodgkin Disease 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Anaplastic 2Dendritic Cell Sarcoma, Interdigitating 2Vomiting 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Neoplasms, Plasma Cell 1Nausea 1Multiple Myeloma 1Lymphoma, Primary Effusion 1Lymphoma, AIDS-Related 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Hairy Cell 1Intraocular Lymphoma 1

Interventions

Cyclophosphamide 6fludarabine phosphate 5Peripheral Blood Stem Cell Transplantation 5Filgrastim 4Whole-Body Irradiation 3Rituximab 3Etoposide 3Cytarabine 3Carmustine 3Therapeutics 2Tacrolimus 2Saline Solution 2Radiotherapy 2Polymerase Chain Reaction 2Pentetic Acid 2O(6)-benzylguanine 2Methotrexate 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Gemcitabine 2Fibroblast Growth Factor 7 2Dexamethasone 2Busulfan 2sargramostim 1romidepsin 1plerixafor 1pembrolizumab 1merphos 1fludarabine 1ferric pyrophosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Hodgkin Disease × Rituximab × Clear all
NCT02408042 2017-06-27

Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme)

Western Regional Medical Center

Phase 1/2 Withdrawn
Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT02961816 2017-04-21

Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

NCT00881387 2016-12-15

Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to Treatment

University of Miami

Phase 2 Withdrawn
Lymphoid

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡